|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: TEXAS BIOTECHNOLOGY CORP /DE/, 10-Q, 2000-11-14 |
Next: CITIZENS FINANCIAL CORP /KY/, 10-Q, 2000-11-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JUL-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 34,635,549
<SECURITIES> 47,291,184
<RECEIVABLES> 3,341,943
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 86,424,602
<PP&E> 9,916,336
<DEPRECIATION> (7,319,577)
<TOTAL-ASSETS> 99,080,952
<CURRENT-LIABILITIES> 3,585,474
<BONDS> 0
0
0
<COMMON> 204,756
<OTHER-SE> 87,310,446
<TOTAL-LIABILITY-AND-EQUITY> 87,515,202
<SALES> 0
<TOTAL-REVENUES> 1,649,573
<CGS> 0
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 3,784,971
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> (1,908,730)
<INCOME-TAX> 0
<INCOME-CONTINUING> (1,908,730)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (1,908,730)
<EPS-BASIC> (.05)
<EPS-DILUTED> (.05)
</TABLE>
|
|